Het alfapump®-systeem is momenteel niet goedgekeurd in de Verenigde Staten of Canada. In de Verenigde Staten en Canada wordt het alfapump®-systeem momenteel klinisch onderzocht (POSEIDON-studie) en wordt het bestudeerd bij volwassen patiënten met refractaire of terugkerende ascites als gevolg van cirrose. Voor meer informatie over de POSEIDON klinische studie zie www.poseidonstudy.com.
De DSR®-therapie is nog in ontwikkeling en er dient te worden opgemerkt dat eventuele verklaringen met betrekking tot veiligheid en efficiëntie voortkomen uit lopende preklinische en klinische onderzoeken die nog moeten worden afgerond.
De DSR®-therapie is momenteel niet goedgekeurd voor klinisch onderzoek in de Verenigde Staten of Canada. Er is geen verband tussen de DSR®-therapie en de lopende onderzoeken met het alfapump®-systeem in Europa.

Company overview

Founded in 2006

Over 60 employees

Proprietary alfapump® & DSR technologies

Headquarters in Ghent, Belgium

Manufacturing in Zurich, Switzerland

Listed on Euronext Brussels

Media Library

In the news

Catch-up on our latest news coverage

Info sheet

Learn more about NASH, ascites, diuretic-resistant fluid overload and heart failure.


Watch and learn more about Sequana Medical, our alfapump® & DSR technologies and target disease areas.

Blog Post

Follow Sequana Medical’s blog posts.

Annual report

Discover more about our business activities in our latest annual report.

News, events and presentations

Read our latest news and discover upcoming & recent presentations.


Best Overall Medical Device Product Award
4th Annual Medtech Breakthrough Awards, May 2020

Highly Commended Accolade within the Medtech of the Year Award
2019 Lifestars Awards, November 2019

Media Kit

Download our company logo and pictures.


For any kind of Media inquiry, please get in touch and our team will answer all of your questions.



    We would like to use cookies to better understand your use of this website. This enables us to improve your future experience on our website. Detailed information about the use of cookies on this website and how you can manage or withdraw your consent at any time can be found in our. Privacy & Cookie Policy

    The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.